Welcome
Support Centre
09 January 2009 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effect of high volume saline enemas during labour - randomised controlled trial
ISRCTN ISRCTN43153145
ClinicalTrials.gov identifier
Public title Effect of high volume saline enemas during labour - randomised controlled trial
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis The main objective of this trial was to determine if the use of high volume enemas during the first stage of labour modified neonatal and/or puerperal infectious rates. The null hypothesis stated that infectious morbidity was similar for intervention and control groups. A secondary objective was to establish if there is any effect on specific neonatal or puerperal infectious rates and other clinically relevant outcomes.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Colombia
Disease/condition/study domain Puerperal and neonatal infections
Participants - inclusion criteria 1. Women attending labour ward at low risk for delivery
2. Greater than 36 week gestation
3. In labour
4. Cervix dilatation <8 cm
Participants - exclusion criteria Clinical diagnosis of any systemic or gynaecological bacterial infection, use of systemic antibiotics during the week prior to admission, rupture of amniotic membranes or doubt of their integrity, and a cervical dilatation greater than or equal to 7 cm.
Anticipated start date 01/02/1997
Anticipated end date 28/02/1998
Status of trial Completed
Patient information material
Target number of participants 443
Interventions Enema versus no enema. Block randomisation allocation with sealed envelopes.
Primary outcome measure(s) The primary outcomes were infections in newborns and /or puerperal women. During the analysis, neonatal and puerperal infections were described individually and then amalgamated into a new outcome. This outcome was the 'combined maternal-neonatal outcome'.

A neonatal outcome was positive when during follow-up, any of the following clinical conditions were diagnosed : ocular infection (defined as purulent drainage in the eye after the sixth day of delivery); umbilical infection (foul smell with periumbilical erythema); skin infection (cellulitis or impetigo); respiratory tract infection (clinical diagnosis of lower or upper respiratory tract infection); intestinal infection; meningitis, sepsis or if the child had been prescribed systemic antibiotics during the first month of life.

Positive puerperal outcomes were registered when the mother had any of the following conditions diagnosed by a health care provider: any suture dehiscence, purulent effusion from the episiorraphy, urinary tract infection, pelvic inflammatory disease or vulvovaginitis. While hospitalised, participating women and newborns were visited on a daily basis. Throughout the process data were gathered by trained research assistants using standardised questionnaires. Formats were also used to register data retrieved from telephone calls, during hospitalisation, at follow-up visits and when any communication was established with participants, their families or health care providers.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding 1. International Clinical Epidemiology Network seed grant
2. Enemas donated by Baxter (without detailed knowledge of research protocol)
3. Own funds provided by Luis Gabriel Cuervo
4. Logistics by the School of Medicine at the Universidad Javeriana in Bogota
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/pubmed/16545140
Contact name Dr  Luis Gabriel  Cuervo
  Address 525 23rd St, NW
  City/town Washington
  Zip/Postcode DC 20037-2895
  Country United States of America
  Tel + 1 202 974 3135
  Fax +1 202 974 3652
  Email lgcuervo@gmail.com
Sponsor INCLEN Trust (USA)
  Address 1420 Walnut Street, Suite 411
  City/town Philadelphia
  Zip/Postcode 19102-4003
  Country United States of America
  Tel +1 215 222 7700
  Fax +1 215 222 7741
  Email inclen@inclen.org
  Sponsor website: http://www.inclentrust.org
Date applied 20/03/2002
Last edited 11/04/2008
Date ISRCTN assigned 20/03/2002
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central